AIFA holds conference in Genoa on pharmaceutical innovation value

The Italian Medicines Agency (AIFA) held a conference in Genoa titled ‘Measuring the Value of Innovation – From Drug Evaluation to Health Outcomes.’ Organized with the patronage of the Liguria Region, the event is part of a series of institutional meetings aimed at strengthening dialogue between AIFA, regional institutions, and stakeholders involved in drug governance.

The discussions focused on the need to develop advanced models for evaluating pharmaceutical innovation. Participants emphasized that evaluation should extend beyond clinical efficacy to include the concrete impact on patient lives, healthcare organization, and the overall sustainability of the Italian National Health Service. A central theme was the balance between fostering innovation and ensuring economic sustainability within pharmaceutical assistance strategies.